MNOV: MN-166 Making Progress in Numerous Indications…
Yahoo! Finance USA,
By David Bautz, PhD NASDAQ:MNOV MN-166 in ALSThere have been a number of recent announcements regarding MN-166 (ibudilast) in…
Brain Atrophy in Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis: Longitudinal Quantitative Analysis
Overview of attention for article published in Radiology, March 2000
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
High Attention Score compared to outputs of the same age and source (96th percentile)
Readers on
- mendeley
- 96 Mendeley